XML 45 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of Exercise Of Pre-Funded Warrants Information on the outstanding warrants is as follows:
TypeExercise PriceAmountType of Financing
Common stock pre-funded warrant$0.000001 425,987Legacy pre-funded warrants outstanding
Common stock pre-funded warrant$0.000001 1,708,332December 2023 preferred stock conversion
Common stock pre-funded warrant$0.000001 1,825,635December 2023 Pre-Closing Financing
Common stock pre-funded warrant$0.001 2,165,042November 2024 private placement
Common stock pre-funded warrant$0.001 667,563April 2025 common stock conversion
Total6,792,559
Schedule of Common Stock Reserved for Future Issuance
The Company has reserved shares of the Company’s common stock for future issuance as follows:
September 30,
2025		December 31,
2024
Unvested restricted stock units257,797 222,530 
Unvested performance stock units252,124 252,124 
Options outstanding2,112,391 1,387,556 
Shares available for future grant under the 2023 Equity Incentive Plan1,264,0891,458,188
Shares available for future grant under the 2025 Inducement Plan
409,490—
Shares available for future issuance under the 2023 Employee Stock Purchase Plan321,770173,223
Pre-funded warrants outstanding6,792,5596,124,996
Total common stock reserved11,410,2209,618,617